{"id":510498,"date":"2021-07-07T16:04:23","date_gmt":"2021-07-07T20:04:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/"},"modified":"2021-07-07T16:04:23","modified_gmt":"2021-07-07T20:04:23","slug":"eyenovia-to-participate-in-two-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/","title":{"rendered":"Eyenovia to Participate in Two Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, July  07, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZpgzJNTia-oXU5CBiLr2Cd5dSq9aPVzULKhzf8GznCfajtiLYBq5bOhs06OR_lv6ZNn_KITvFRpWomyyzlL5Cw==\" rel=\"nofollow noopener\" target=\"_blank\">Eyenovia, Inc.<\/a> (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP\u2122) platform technology, today announced that management will present a corporate overview and host one-one-one meetings at the Ladenburg Thalmann 2021 Healthcare Conference, being held virtually July 13-14, 2021, and host one-on-meetings at the William Blair Biotech Focus Conference 2021, being held virtually July 14-15, 2021.<\/p>\n<p align=\"justify\">Details of the Ladenburg presentation are below:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:8%;width:8%;min-width:8%;text-align: justify;vertical-align: middle;vertical-align: top\">Date:<\/td>\n<td style=\"max-width:92%;width:92%;min-width:92%;text-align: justify;vertical-align: middle;vertical-align: top\">Wednesday, July 14, 2021<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Time:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">9:00AM Eastern Time<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Webcast:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <a href=\"https:\/\/shared.outlook.inky.com\/link?domain=wsw.com&amp;t=eyJ0eXAiOiJKV1QiLCJhbGciOiJFUzI1NiJ9.eJxtUF1vgjAU_S99NkPEZcqTy9iWGanRsTAIiSlwHYW2kt4qwrL_vrLHxbebnI97zvkmBpjkJfGJ4EfAgrPywvGkkUwIVwa0YoL4RyYQJgQsrWlZr2CFvWxPyBlcQBm8K07SCkabm8BZWxNSGdOinzmZ02E3IvaAvGBoMkewElR-1l8PmQM9qMyZzWfufLm06u0H8dVZiAkxlQZmDsKaW8OpjTi-zF-FTD9pzeKXppRiyL31sPH2Qxqvq8Lbt0l8_3iTI-klf190NKYNjcJrGu26bdBM0-jZC4OkT4aqosHOTes930bFPH1aXGn95oZ16NIh6TZ10Y_lEPQBJOPiwMpSA6LNZBByW4wztfo37N8kP7_hQ4PK.MEUCIQCcNm7oMWHTcMb58Q4bMlXdYyg4gG162mhDJEmaNOhyogIgPYIciEpQzCUw77Yyt3zZ6wumZ-3b-sq4AmbB-jcffMM\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/ladenburg7\/eyen\/2421499<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About\u00a0Eyenovia, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Eyenovia, Inc.\u00a0(NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics.\u00a0Eyenovia\u00a0is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1uRbzw6OsEDHJZJZE_f_UXga6UJbEvw45-udZ7nJRJXRUiVekaVWy5y4kMDDk3gDGt0aqzjuICGdo8CIbihSwg==\" rel=\"nofollow noopener\" target=\"_blank\">www.eyenovia.com<\/a>.<\/p>\n<p>The Eyenovia Corporate Information slide deck may be found at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9hPnpiorLw1p4mxzItsG0at3FhQ39rLOZAqQoFMhVqS_iniRaTybOGpo2GjWCsOgWgeTBTBOFH9llWf-MZMHA3k28y01h178_AVZdHWwPCROW5_WbHVOHO_U0Vz5DCFheeMzTcekj0noOKqu9y3swg==\" rel=\"nofollow noopener\" target=\"_blank\">ir.eyenovia.com\/events-and-presentations<\/a>.<\/p>\n<p>\n        <strong>Eyenovia Contact:<\/strong><br \/>\n        <br \/>Eyenovia, Inc.<br \/>John Gandolfo<br \/>Chief Financial Officer<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pdnALIl9EUAgZ-cqQQnnGUamlFcrF1-nsnkBjDzoOnfa8YbY5cf8fMZUzemASHbJ_UQXf6irAZdhhHDWeF4h_sd0KcBhD2N770Q6nR6IjRQ=\" rel=\"nofollow noopener\" target=\"_blank\">jgandolfo@eyenovia.com<\/a><\/u><\/p>\n<p>\n        <strong>Eyenovia Investor Contact:<\/strong><br \/>\n        <br \/>Eric Ribner<br \/>LifeSci Advisors, LLC<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tznplFeD6Fks5Rgr8cIJ3-OROXTRXO1c3GlojXqTbc6RebS2N1pvS-NkGP5b6IprFN5PXn3MbL0K6Ix4fupODEAiEV7-6LEqLO-RD-rmQow=\" rel=\"nofollow noopener\" target=\"_blank\">eric@lifesciadvisors.com<\/a><\/u><br \/>(646) 751-4363<\/p>\n<p>\n        <strong>Eyenovia Media Contact:<\/strong><br \/>\n        <br \/>Sam Choinski<br \/>Pazanga Health Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xNBuVysr8HGoxniYk1WQddDY-aOX4_x6et1Zyo1H-fzTsxyxbMo-Bpa_Cxq4bTDuqWb0NXxT5znM32behBPtPMIR4LXUiJfGJbPKM0iKCrz4yHgaYz-j_qQt4qF2De9M\" rel=\"nofollow noopener\" target=\"_blank\">schoinski@pazangahealth.com<\/a><br \/>(603) 489-5964<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/578ed5b1-0115-4917-b1fc-3dc9c05c0d59\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) &#8212; Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP\u2122) platform technology, today announced that management will present a corporate overview and host one-one-one meetings at the Ladenburg Thalmann 2021 Healthcare Conference, being held virtually July 13-14, 2021, and host one-on-meetings at the William Blair Biotech Focus Conference 2021, being held virtually July 14-15, 2021. Details of the Ladenburg presentation are below: Date: Wednesday, July 14, 2021 Time: 9:00AM Eastern Time Webcast: https:\/\/wsw.com\/webcast\/ladenburg7\/eyen\/2421499 About\u00a0Eyenovia, Inc. Eyenovia, Inc.\u00a0(NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics.\u00a0Eyenovia\u00a0is currently focused on the late-stage &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Eyenovia to Participate in Two Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-510498","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eyenovia to Participate in Two Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eyenovia to Participate in Two Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) &#8212; Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP\u2122) platform technology, today announced that management will present a corporate overview and host one-one-one meetings at the Ladenburg Thalmann 2021 Healthcare Conference, being held virtually July 13-14, 2021, and host one-on-meetings at the William Blair Biotech Focus Conference 2021, being held virtually July 14-15, 2021. Details of the Ladenburg presentation are below: Date: Wednesday, July 14, 2021 Time: 9:00AM Eastern Time Webcast: https:\/\/wsw.com\/webcast\/ladenburg7\/eyen\/2421499 About\u00a0Eyenovia, Inc. Eyenovia, Inc.\u00a0(NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics.\u00a0Eyenovia\u00a0is currently focused on the late-stage &hellip; Continue reading &quot;Eyenovia to Participate in Two Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-07T20:04:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Eyenovia to Participate in Two Upcoming Investor Conferences\",\"datePublished\":\"2021-07-07T20:04:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/\"},\"wordCount\":193,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/\",\"name\":\"Eyenovia to Participate in Two Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=\",\"datePublished\":\"2021-07-07T20:04:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyenovia-to-participate-in-two-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eyenovia to Participate in Two Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eyenovia to Participate in Two Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Eyenovia to Participate in Two Upcoming Investor Conferences - Market Newsdesk","og_description":"NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) &#8212; Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP\u2122) platform technology, today announced that management will present a corporate overview and host one-one-one meetings at the Ladenburg Thalmann 2021 Healthcare Conference, being held virtually July 13-14, 2021, and host one-on-meetings at the William Blair Biotech Focus Conference 2021, being held virtually July 14-15, 2021. Details of the Ladenburg presentation are below: Date: Wednesday, July 14, 2021 Time: 9:00AM Eastern Time Webcast: https:\/\/wsw.com\/webcast\/ladenburg7\/eyen\/2421499 About\u00a0Eyenovia, Inc. Eyenovia, Inc.\u00a0(NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics.\u00a0Eyenovia\u00a0is currently focused on the late-stage &hellip; Continue reading \"Eyenovia to Participate in Two Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-07T20:04:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Eyenovia to Participate in Two Upcoming Investor Conferences","datePublished":"2021-07-07T20:04:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/"},"wordCount":193,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/","name":"Eyenovia to Participate in Two Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=","datePublished":"2021-07-07T20:04:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjczNyM0Mjg2ODA1IzIwODE4NDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyenovia-to-participate-in-two-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Eyenovia to Participate in Two Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=510498"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510498\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=510498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=510498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=510498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}